SK Capital Partners has acquired a majority stake in Halo Pharmaceutical for an undisclosed amount.

Halo, headquartered in Whippany, New Jersey, provides outsourced development and manufacturing services to the pharmaceutical industry.  The company makes solid, semi-solid and liquid medicines, with a particular focus on controlled substances.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.